A detailed history of North Star Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, North Star Asset Management Inc holds 16,100 shares of LLY stock, worth $12.7 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
16,100
Previous 16,317 1.33%
Holding current value
$12.7 Million
Previous $14.8 Million 3.45%
% of portfolio
0.67%
Previous 0.73%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $167,554 - $208,324
-217 Reduced 1.33%
16,100 $14.3 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $450,144 - $564,513
-621 Reduced 3.67%
16,317 $14.8 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $41,454 - $55,459
-70 Reduced 0.41%
16,938 $13.2 Million
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $277,825 - $327,519
-529 Reduced 3.02%
17,008 $9.91 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $221,697 - $305,643
-510 Reduced 2.83%
17,537 $9.42 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $795,829 - $1.06 Million
-2,269 Reduced 11.17%
18,047 $8.46 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $111,205 - $130,605
-358 Reduced 1.73%
20,316 $6.98 Million
Q4 2022

Mar 06, 2023

SELL
$321.55 - $374.67 $1.2 Million - $1.4 Million
-3,739 Reduced 15.32%
20,674 $7.56 Million
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $274,244 - $312,529
-925 Reduced 3.65%
24,413 $7.89 Million
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $757,866 - $889,847
-2,719 Reduced 9.69%
25,338 $8.22 Million
Q1 2022

Apr 29, 2022

SELL
$234.69 - $291.66 $72,519 - $90,122
-309 Reduced 1.09%
28,057 $8.03 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $144,803 - $179,701
644 Added 2.32%
28,366 $7.84 Million
Q3 2021

Oct 20, 2021

BUY
$221.6 - $272.71 $116,561 - $143,445
526 Added 1.93%
27,722 $6.41 Million
Q2 2021

Jul 30, 2021

BUY
$180.55 - $233.54 $342,322 - $442,791
1,896 Added 7.49%
27,196 $6.24 Million
Q1 2021

Apr 29, 2021

BUY
$164.32 - $212.72 $336,527 - $435,650
2,048 Added 8.81%
25,300 $4.73 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $2.72 Million - $3.6 Million
20,872 Added 876.97%
23,252 $3.93 Million
Q2 2020

Jul 28, 2020

BUY
$136.42 - $164.18 $2,728 - $3,283
20 Added 0.85%
2,380 $391,000
Q1 2020

Apr 24, 2020

SELL
$119.05 - $147.35 $150,003 - $185,661
-1,260 Reduced 34.81%
2,360 $327,000
Q3 2019

Oct 25, 2019

SELL
$106.79 - $116.16 $5,339 - $5,808
-50 Reduced 1.36%
3,620 $405,000
Q3 2018

Oct 29, 2018

SELL
$85.86 - $107.31 $5,580 - $6,975
-65 Reduced 1.74%
3,670 $394,000
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $3,785 - $4,344
-50 Reduced 1.32%
3,735 $319,000
Q4 2017

Feb 01, 2018

BUY
$81.94 - $87.89 $92,182 - $98,876
1,125 Added 42.29%
3,785 $320,000
Q2 2017

Aug 16, 2017

BUY
N/A
2,660
2,660 $219,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.